Non-vitamin K antagonist oral anticoagulants versus warfarin in patients with atrial fibrillation and liver disease: a meta-analysis and systematic review

Y Fu, W Zhu, Y Zhou, H Chen, L Yan, W He - American Journal of …, 2020 - Springer
Background The effect of non-vitamin K antagonist oral anticoagulants (NOACs) in patients
with atrial fibrillation (AF) and liver disease remains largely unresolved. Therefore, we
performed a meta-analysis to compare the efficacy and safety of NOACs with warfarin in this
population. Methods We systematically searched the Cochrane Library, PubMed, and
Embase databases for studies reporting the comparisons of NOACs with warfarin in patients
with AF and liver disease. A random-effects model was selected to pool the risk ratios (RRs) …
被引用次数：20 相关文章 所有 3 个版本

Non-vitamin K antagonist oral anticoagulants versus warfarin in patients with atrial fibrillation and peripheral artery disease: a systematic review and meta-analysis

XZ Liao, YH Fu, JY Ma, WG Zhu, P Yuan - Cardiovascular Drugs and …, 2020 - Springer
Background The efficacy and safety of non-vitamin K antagonist oral anticoagulants
(NOACs) compared with warfarin in patients with atrial fibrillation (AF) and peripheral artery
disease (PAD) remain largely unknown. Therefore, we conducted a meta-analysis to explore
the effects of NOACs versus warfarin in this population. Methods We systematically
searched the PubMed and Embase databases, with no linguistic restrictions, until December
2019 for relevant randomized controlled trials (RCTs) and observational studies. A random …
被引用次数：15 相关文章 所有 5 个版本
以上显示的是最相近的搜索结果。 查看全部搜索结果